is more efficacious than a bisphosphonate for the treatment of glucocorticoid-induced osteoporosis (GIO), according to a multinational study led by Kenneth Saag in the USA. The results ...

The Department is delighted to announce that Ken Saag, M.D., M.Sc. will serve as our next Director of the Division of Clinical Immunology and Rheumatology, effective July 1, 2020. Ken will build on an ...

Division Director Kenneth G. Saag, M.D., MSc., attributes the longstanding record of excellence to the vision and dedication of the entire healthcare team. “There is a history here of extraordinary ...